Revolutions Medical to distribute FDA-approved breast biopsy system
Revolutions Medical has signed a worldwide exclusive license with Strategic Product Development for an image-guided navigation system that incorporates a breast biopsy system with conventional mammography systems.
BBS facilitates non-palpable lesions and micro-calcification localization in the treatment of breast cancer, according to the Mount Pleasant, S.C.-based company. BBS offers advantages for the localization and biopsy of breast abnormalities. The system can also be modified to leverage existing popular biopsy tools. The technology can be used to provide a technology platform for future development including multi-modal breast imaging for the image fusion of MRI and x-ray images.
BBS facilitates non-palpable lesions and micro-calcification localization in the treatment of breast cancer, according to the Mount Pleasant, S.C.-based company. BBS offers advantages for the localization and biopsy of breast abnormalities. The system can also be modified to leverage existing popular biopsy tools. The technology can be used to provide a technology platform for future development including multi-modal breast imaging for the image fusion of MRI and x-ray images.